{"slug":"eye","tag":"eye","variants":["eye"],"description":"No description yet","count":2,"kinds":{"cancer":2},"related":[{"slug":"hereditary","tag":"hereditary","shared":1},{"slug":"paediatric","tag":"paediatric","shared":1},{"slug":"rare","tag":"rare","shared":1},{"slug":"skin","tag":"skin","shared":1}],"records":[{"id":"uveal-melanoma","kind":"cancer","name":"Uveal melanoma","route":"/cancers/uveal-melanoma/","tldr":"A melanoma inside the eye that is biologically unrelated to skin melanoma: different mutations, no response to standard immunotherapy, and a tendency to spread to the liver years later. Tebentafusp is the first drug ever to extend survival in the metastatic disease."},{"id":"retinoblastoma","kind":"cancer","name":"Retinoblastoma","route":"/cancers/retinoblastoma/","tldr":"An eye cancer of infants caused by loss of the RB1 gene, the first tumour-suppressor gene ever found. In rich countries almost every child survives and most eyes are saved by chemotherapy delivered through the eye's artery; in low-income countries, where most cases occur, survival depends on finding it early, and that is the global gap."}]}